InvestorsHub Logo
Followers 0
Posts 568
Boards Moderated 0
Alias Born 05/24/2013

Re: None

Sunday, 06/09/2013 10:42:57 PM

Sunday, June 09, 2013 10:42:57 PM

Post# of 443
Breast Cancer As First Targeted Indication. Roche dominates the breast cancer industry with its Herceptin and related products targeting HER-2 positive patients. Roche products only are designed for 20 percent of the breast cancer population, yet generate about $6 billion in sales annually. Sunshine Biopharma’s Adva-27a target a larger population.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMGN News